Access to Care and the Incidence of Endstage Renal Disease Due to Systemic Lupus Erythematosus

被引:29
|
作者
Ward, Michael M. [1 ]
机构
[1] NIAMSD, Intramural Res Program, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ACCESS TO CARE; SOCIOECONOMIC STATUS; ENDSTAGE RENAL DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SOCIOECONOMIC-STATUS; RISK-FACTORS; NEPHRITIS; ASSOCIATION; RACE; MORBIDITY; INSURANCE; COHORT; HEALTH; ONSET;
D O I
10.3899/jrheum.091199
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Persons with low socioeconomic status have an increased risk of endstage renal disease (ESRD) due to systemic lupus erythematosus (SLE), possibly because of limited access to care. We examined if the incidence of ESRD due to SLE was higher in geographic areas with poorer access to care. Methods. In this population-based ecological study, we tested associations between the incidence of ESRD due to SLE and the proportion of hospitalizations with no insurance, Medicaid or managed care insurance, residence in a primary care-provider shortage area or rural area, and rate of hospitalizations for ambulatory care-sensitive conditions, by ZIP code in California in 1999-2004. Results. The incidence of ESRD due to SLE was higher in ZIP codes with higher proportions of hospitalizations with no insurance (r = 0.22, p<0.0001) or Medicaid (r = 0.21, p<0.0001), and in ZIP codes with higher rates of hospitalizations for ambulatory care-sensitive conditions (r = 0.23, p<0.0001). In multivariate analyses, incidences were higher in ZIP codes with higher proportions of hospitalizations with Medicaid (p<0.0001) and higher rates of hospitalizations for ambulatory care-sensitive conditions (p = 0.06), independent of the socioeconomic status of the ZIP code residents. Conclusion. The incidence of ESRD due to SLE is higher in areas with higher proportions of residents who have public insurance and higher rates of avoidable hospitalizations, suggesting that limited access to care may contribute to this complication of SLE. (First Release April 15 2010; J Rheumatol 2010;37:1158-63; doi:10.3899/jrheum.091199)
引用
收藏
页码:1158 / 1163
页数:6
相关论文
共 50 条
  • [41] INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS BY AGE AND SEX
    MADDOCK, RK
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 191 (02): : 137 - &
  • [42] INCIDENCE OF INFECTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    STAPLES, PJ
    GERDING, DN
    DECKER, JL
    GORDON, RS
    ARTHRITIS AND RHEUMATISM, 1974, 17 (01): : 1 - 10
  • [43] Renal Disease in Systemic Lupus Erythematosus With Emphasis on Classification of Lupus Glomerulonephritis Advances and Implications
    Seshan, Surya V.
    Jennette, J. Charles
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (02) : 233 - 248
  • [44] CANCER INCIDENCE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Fernandez Matilla, M.
    Grau Garcia, E.
    Poveda Marin, G.
    Feced Olmos, C.
    Labrador Sanchez, E.
    Ortiz Sanjuan, F. M.
    Fernandez-Llanio, N.
    Hervas Marin, D.
    Fornes Ferrer, V.
    Arevalo Ruales, K.
    Negueroles Albuixech, R.
    Ivorra Cortes, J.
    Fragio Gil, J.
    Martinez Cordellat, I.
    Valero Sanz, J.
    Chalmeta Verdejo, I.
    Gonzalez Puig, L.
    Alcaniz Escandell, C.
    Najera Herranz, C.
    Castellano Cuesta, J.
    Roman Ivorra, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1070 - 1070
  • [45] Incidence of Thyroid Disorders in Systemic Lupus Erythematosus
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Ruffilli, Ilaria
    Mosca, Marta
    Fallahi, Poupak
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] Systemic Lupus Erythematosus for Primary Care
    Kado, Ruba
    PRIMARY CARE, 2018, 45 (02): : 257 - +
  • [47] Role of lipids in the progression of renal disease in systemic lupus erythematosus patients
    Luzar, B
    Ferluga, D
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (15-16) : 716 - 721
  • [48] PATHOGENIC MECHANISMS, ACTIVITY AND DAMAGE OF THE RENAL DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Toledano Marlene, Guibert
    Reyes Llerena Gil, A.
    Ida Rosa, Lopez Aguilera
    Lopez Mantecon Ana, M.
    Stivens Adelaida, Garcia
    Gonzalez Marlen, Izquierdo
    Junco Victo, L.
    REVISTA CUBANA DE REUMATOLOGIA, 2006, 8 (9-10): : 52 - 64
  • [49] Risk factors for renal disease in systemic lupus erythematosus and their clinical implications
    Ntatsaki, Eleana
    Isenberg, David
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (07) : 837 - 848
  • [50] Calciphylaxis in the Absence of Renal Disease: Secondary Hyperparathyroidism and Systemic Lupus Erythematosus
    Zechlinski, Joseph John
    Angel, Joel R.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2370 - 2372